Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Neonatal Lupus and IUGR Following Alpha-Interferon Therapy during Pregnancy

Journal of Perinatology volume 25, pages 552–554 (2005)Cite this article

Abstract

Interferon alfa-2a is a cytokine produced by recombinant DNA techniques and has antiproliferative, antiviral and immunomodulating effects. A number of case reports in the past have suggested relative safety of alpha-interferons during pregnancy with little or no effect on the fetus. A 15-year-old adolescent became pregnant while receiving alpha-interferon for essential thrombocythemia. She delivered a small-for-gestational age baby girl at 33 weeks gestation. The infant displayed a facial rash characteristic of neonatal lupus and transient thrombocytopenia; maternal and neonatal serologies were typical for drug-induced lupus. These findings suggest probable association between maternal use of alpha interferon and adverse effects in the fetus.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hiratsuka M, Minakami H, Koshizuka S, et al. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 2000;28 (5):372–376.

    Article  CAS  Google Scholar 

  2. Griesshammer M, Heimpel H, Pearson TC . Essential thrombocythemia and pregnancy. Leuk Lymphoma 1996;22 (Suppl 1):57–63.

    Article  Google Scholar 

  3. Wright CA, Tefferi A . A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001;66 (3):152–159.

    Article  CAS  Google Scholar 

  4. Harrison CN . Current trends in essential thrombocythaemia. Br J Haematol 2002;117 (4):796–808.

    Article  CAS  Google Scholar 

  5. Deininger MW, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia. Blood 2000;96 (10):3343–3356.

    CAS  PubMed  Google Scholar 

  6. Chow EY, Haley LP, Vickars LM . Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome. Am J Hematol 1992;41 (4):249–251.

    Article  CAS  Google Scholar 

  7. White PH . Pediatric systemic lupus erythematosus and neonatal lupus. Rheum Dis Clin North Am 1994;20 (1):119–127.

    CAS  PubMed  Google Scholar 

  8. Cincotta R, Higgins JR, Tippett C, et al. Management of essential thrombocythaemia during pregnancy. Aust N Z J Obstet Gynaecol 2000;40 (1):33–37.

    Article  CAS  Google Scholar 

  9. Pons JC, Lebon P, Frydman R, et al. Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal Diagn Ther 1995;10 (1):7–10.

    Article  CAS  Google Scholar 

  10. Haggstrom J, Adriansson M, Hybbinette T, et al. Two cases of CML treated with alpha-interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum. Eur J Haematol 1996;57 (1):101–102.

    Article  CAS  Google Scholar 

  11. Schmidt KN, Ouyang W . Targeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy. Lupus 2004;13 (5):348–352.

    Article  CAS  Google Scholar 

  12. Petri M . Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994;20 (1):87–118.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Yukiko N . Immune responses to SS-A 52-kDa and 60-kDa proteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus. Br J Dermatol 2000;142 (5):908–912.

    Article  CAS  Google Scholar 

  14. von Marschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst 2003;95 (6):437–448.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr Shalini Shenoy and Dr Bharti Razdan for their help in preparation of this manuscript.

Author information

Authors and Affiliations

  1. University of Pittsburgh (M.F.), Pittsburgh, PA, USA

    Melinda Fritz MD

  2. Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation (K.V.), Children's Hospital of Pittsburgh, Pittsburgh, PA, USA

    Kalyani Vats MD

  3. Division of Neonatology (R.K.G.), Children's Hospital of Pittsburgh, Pittsburgh, PA, USA

    Rakesh K Goyal MD

Authors
  1. Melinda Fritz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kalyani Vats MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rakesh K Goyal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fritz, M., Vats, K. & Goyal, R. Neonatal Lupus and IUGR Following Alpha-Interferon Therapy during Pregnancy. J Perinatol 25, 552–554 (2005). https://doi.org/10.1038/sj.jp.7211342

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211342

This article is cited by

Search

Advanced search

Quick links